| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |